Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Abnormal Proliferation02:23

Abnormal Proliferation

4.0K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Use of corticosteroids in sepsis and infectious diseases: a narrative review.

The Korean journal of internal medicine·2026
Same author

Promoting Gas Sensitivity of Graphitic Carbon Nitride via Incorporation of Platinum Nanoparticles under Blue-Light Irradiation.

ACS sensors·2026
Same author

Incidence and preoperative risk factors for failed back surgery syndrome: a nationwide population-based cohort study.

Scientific reports·2026
Same author

Clonal relationship in a rare pulmonary mixed tumor: shared ALK fusion in atypical carcinoid and adenocarcinoma-a case report.

Translational lung cancer research·2026
Same author

Tunable Ni<sub>2</sub>P@polypyrrole nanocomposites for efficient hydrogen evolution and high-performance supercapacitors.

Chemical communications (Cambridge, England)·2026
Same author

Sulforaphene-Enriched Raphanus sativus L. Seed Extract Promotes Norepinephrine-Induced Thermogenesis and Weight Loss by Modulating the Interplay Between Adipocytes and Immune Cells in Adipose Tissue.

Phytotherapy research : PTR·2026

相关实验视频

Updated: May 3, 2026

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice
07:54

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice

Published on: December 21, 2019

6.7K

初级肺部肌状肉瘤:一个病例报告

Jong Hun Kim1, Kyoung Min Kim2

  • 1Department of Thoracic and Cardiovascular Surgery, Jeonbuk National University Hospital, Jeonbuk National University Medical School, Jeonju, Jeollabuk 54907, Republic of Korea.

Oncology letters
|April 23, 2025
PubMed
概括

肺部状肉瘤是一种罕见的肺癌. 本病例报告详细介绍了通过EWSR1-CREB1融合确认的诊断,强调了识别这种罕见瘤的挑战.

科学领域:

  • 在瘤学瘤学.
  • 肺部医学 肺部医学
  • 病理学 病理学 病理学

背景情况:

  • 肺部状肉瘤是一种罕见的肺部恶性瘤.
  • 它的稀有性和非特异性呈现提出了诊断和治疗方面的挑战.
  • 关于其发病,治疗和预后的数据有限.
关键词:
这是EWSR1.EWSR1-CREB1的重新排列方式原发性肺部菌性肉瘤是什么意思

更多相关视频

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines
08:01

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines

Published on: April 21, 2022

1.8K
Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
08:57

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

1.1K

相关实验视频

Last Updated: May 3, 2026

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice
07:54

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice

Published on: December 21, 2019

6.7K
Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines
08:01

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines

Published on: April 21, 2022

1.8K
Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
08:57

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

1.1K